Start
«
1
2
3
»
End
Page 2 of 3
Results 76 - 150 of 182
15
30
60
75
150
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
New Directions in the Diagnosis of RA ILD
Therapies on the Horizon for RA ILD
New Treatment Options for SSc ILD
Updates on Current Treatment Options for RA ILD
Learnings From the Virtual ERS International Congress
Practical Questions in the Diagnosis and Management of Patients With MAC
COVID-19 and ARDS: West Coast Experiences
Biochemical Profiles of Radiographic Patterns in SSc-ILD
Factors Associated with Disease Progression in the SENSCIS Trial
Machine Learning Assisted Prediction of Progression in SSc-ILD
What Have We Learned from Clinical Trials on Sex Differences in SSc-ILD
Efficacy of MMF in African Americans vs Non-African Americans with SSc-ILD
Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis
Updates on Current Treatment Options for RA-ILD
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
Utilizing ACIP's Updated Pneumococcal Recommendations - Rapid Recap
PILOTforPulmonary 2019: Data, Insights & Practice
Managing the Whole Patient with COPD: An Animated Video Series
My COPD Action Plan
Expert Recommendations for COPD
How Can Targeting the Endocannabinoid System Help to Resolve CF Inflammation
Previous Approaches that Tried to Target Inflammation in Cystic Fibrosis
Inflammation in Cystic Fibrosis
Understanding the Endocannabinoid System (Cystic Fibrosis)
Surgical and Minimally Invasive Procedures that Might Benefit COPD Patients
COPD: Fixed Dose Combinations
COPD: Proper Inhaler Use
Clinical Pearls from New Orleans 2019
Inhaled NO in Patients at Risk for Pulmonary Hypertension
Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease
Considerations for Geriatric ILD Patients
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
Emerging Diagnostic Approaches to Patients with ILD
Goals of Care Across the Disease Continuum in IPF
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Current Perspective on Antifibrotic Therapy for Patients with IPF
Pulmonologists as the Gatekeepers of Precision Medicine
Interstitial Pneumonia with Autoimmune Features (IPAF)
How to Identify & Manage Patients with Progressive-Fibrosing ILD
Acute Exacerbations of IPF
Personalized Medicine for Improving Asthma Care: An Animated Video Series
New Developments in Pulmonary Diseases: Optimizing Patient Outcomes
Palliative Medicine in Pulmonology
Patient Education, Adherence, Inhaler Technique, and Pulmonary Rehabilitation
Dyspnea and Disease are Progressing: What to Do?
Thoracic Radiology
A Closer Look at ILD, Sarcoidosis, and CTEPH
New Developments in Pulmonary Diseases: Optimizing Patient Outcomes
Discussions with Patients to Optimize Asthma Control
Who Should be Targeted For Treatment With Biologic Therapy?
Endotypes and Phenotypes in Asthma
Mechanisms of Action of Biologic Therapies for Severe Asthma
Approved Medications for the Treatment of Severe Asthma
Engage Your Patients in Shared Decision-Making
Is It IPF or Cardiovascular Disease?
Interstitial Pneumonia with Autoimmune Features
How to Identify Progressive Fibrosing ILD
When Is It a Connective Tissue Disease?
How to Use IPF Guidelines to Make a Diagnosis
Evaluation and Diagnosis of IPF
Initial Treatment Decisions of IPF
What if President Calvin Coolidge Was Your Asthma Patient?
Optimizing Management of IPF
New Concepts in the Pathobiology of Asthma
When Is a Cough Not Just a Cough?
Diagnosing ILDs Such as IPF and More
Beyond the Basics: Complex ILD Cases
PowerPoint Slides: Achieving Better Control of Severe Asthma
How Would You Manage President Theodore Roosevelt’s Asthma Today?
Eugene’s U(I)P-Hill Battle
Is Mary’s PAH Making You Dizzy?
Jeff’s COPD is No Smoke!
Clearing the Air on Chuck’s Asthma
Start
«
1
2
3
»
End
Page 2 of 3
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our
Privacy Policy
.
I accept